We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Justices Told Fed. Circ. Ruling Made Mayo A 'Dead Letter'

Law360 (January 2, 2019, 5:37 PM EST) -- Hikma Pharmaceuticals has urged the U.S. Supreme Court to reverse a Federal Circuit decision that it says makes all medical treatment methods patent-eligible, an outcome the company said “breaks sharply” from...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.